Qianjiang Yongan Pharmaceutical Co (SZSE:002365) ROCE % : 6.48% (As of Mar. 2024)

View and export this data going back to 2010. Start your Free Trial

What is Qianjiang Yongan Pharmaceutical Co ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Qianjiang Yongan Pharmaceutical Co's annualized ROCE % for the quarter that ended in Mar. 2024 was 6.48%.

Qianjiang Yongan Pharmaceutical Co ROCE % Historical Data

The historical data trend for Qianjiang Yongan Pharmaceutical Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qianjiang Yongan Pharmaceutical Co ROCE % Chart

Qianjiang Yongan Pharmaceutical Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROCE %

Get a 7-Day Free Trial

6.95

7.42

6.88

7.44

0.30

Qianjiang Yongan Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
ROCE %	Get a 7-Day Free Trial															2.82	9.44	0.98	-12.24	6.48

Qianjiang Yongan Pharmaceutical Co ROCE % Calculation

Qianjiang Yongan Pharmaceutical Co's annualized ROCE % for the fiscal year that ended in Dec. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Dec. 2023 )		(A: Dec. 2022 )		(A: Dec. 2023 )
	=	6.426	/	( ( (2424.179 - 285.127)	+	(2347.138 - 257.256) )	/ 2 )
	=	6.426	/	( (2139.052	+	2089.882)	/ 2 )
	=	6.426	/	2114.467
	=	0.30 %

Qianjiang Yongan Pharmaceutical Co's ROCE % of for the quarter that ended in Mar. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Mar. 2024 )		(Q: Dec. 2023 )		(Q: Mar. 2024 )
	=	135.768	/	( ( (2347.138 - 257.256)	+	(2321.956 - 219.879) )	/ 2 )
	=	135.768	/	( ( 2089.882	+	2102.077 )	/ 2 )
	=	135.768	/	2095.9795
	=	6.48 %

(1) Note: The EBIT data used here is four times the quarterly (Mar. 2024) EBIT data.

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Qianjiang Yongan Pharmaceutical Co ROCE % Related Terms

Thank you for viewing the detailed overview of Qianjiang Yongan Pharmaceutical Co's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Qianjiang Yongan Pharmaceutical Co Ltd (SZSE:002365) » Definitions » ROCE %

Traded in Other Exchanges

N/A

Address

No. 2, Guangze Avenue, Qianjiang Economic Development Zone, Hubei Province, Wuhan, CHN, 433100

Website

http://www.chinataurine.com

Qianjiang Yongan Pharmaceutical Co Ltd is a China-based company principally involved in the manufacturing of taurine products. The company sells its products in China and other international countries.

Executives

Mei Song Lin	Executives
Wang Zhi Hua	Executives
Hong Ren Gui	Executives
Wu Yu Xi	Directors, executives
Dai Xiang Zhen	Executives
Wu Xiao Bo	Directors, executives
Luo Bai Neng	Executives
Ding Hong Li	Directors, executives
Fang Xi Quan	Executives
Li Shao Bo	Executives
Deng Yong Hong	Securities Affairs Representative
Dong Shi Hao	Executives
Wu Guo Sen	Supervisors
Lv Xin Wu	Executives
Chen Yong	Directors, executives

Qianjiang Yongan Pharmaceutical Co (SZSE:002365) Headlines

No Headlines